Torrent Pharmaceuticals Limited (TORNTPHARM) — Announcement | 10 September 2025

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Torrent Pharmaceuticals acquired a 26% equity stake in Torrent Urja 27 Private Limited for ₹7.92 crores on September 10, 2025. Torrent Urja is a special purpose vehicle developing a captive hybrid (solar + wind) power project in Gujarat. The investment aims to increase renewable energy usage in Torrent's operations and ensure compliance with Indian electricity regulations. Completion is targeted within 18-20 months. This is a related-party transaction executed at arm's length.

📄 View Original Announcement (PDF)

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TORNTPHARM — Free

Free account · 2 AI queries/day